2025年全球自動注射器市場報告

近年來，自動注射器市場呈指數級成長，市場規模從2024年的37億美元成長至2025年的45.1億美元，複合年成長率達22.0%。過去的成長可歸因於慢性病盛行率的上升、人口老化加劇、生物技術和製藥行業的興起、偏好對自我注射的偏好日益成長以及監管支持。

預計未來幾年自動注射器市場規模將呈指數級成長，到2029年將達到99.3億美元，複合年成長率為21.8%。預測期內的成長可歸因於治療應用的不斷擴展、醫療成本的不斷上漲、對以患者為中心的護理、遠端醫療和遠端患者監護的日益關注，以及新興市場的蓬勃發展。預測期間的主要趨勢包括個人化給藥、連網智慧自動注射器、無針自動注射器、生技藥品輸送、安全安全功能。

自動注射器是一種用於自行注射單劑量藥物的裝置，通常採用彈簧式注射器，透過對身體施加強力壓力來啟動。

自動注射器主要分為一次性和可重複使用兩種類型。一次性自動注射器市場包括旨在取代傳統預填充式注射器的設備，透過將針頭隱藏在患者視線之外，消除了患者心理障礙。這些自動注射器整合了屏蔽針頭和彈簧驅動機構，用於皮下或肌肉注射所需藥物。它們可用於多種治療，包括類風濕性關節炎、多發性硬化症、糖尿病和過敏反應，可透過皮下或肌肉注射途徑給藥。分銷管道包括線上零售商和藥局，並用於各種場所，包括居家醫療、醫院和診所。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、加強標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供自動注射器市場統計數據，包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的自動注射器細分市場、市場趨勢和機遇，以及您在自動注射器行業取得成功所需的數據。本自動注射器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長21.8%，較先前預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響將直接影響美國，導致德國精密彈簧和日本針頭安全裝置的供應延遲，可能會擾亂慢性病的治療。此外，互惠關稅以及貿易緊張局勢加劇和限制措施對全球經濟和貿易的負面影響也將更為廣泛地顯現。

預計未來幾年慢性病盛行率的上升將推動自動注射器市場的成長。慢性病是指持續時間超過一年並需要持續治療的疾病。心臟病、癌症、類風濕性關節炎和糖尿病等疾病是全球死亡和殘疾的主要原因。自動注射器旨在為需要定期給藥以長期治療糖尿病和類風濕性關節炎等疾病的患者多次注射生技藥品或荷爾蒙。例如，根據美國衛生組織美國癌症協會在 2022 年 1 月發布的一項調查，到那年，美國癌症死亡人數預計將達到 609,360 人，新增癌症病例預計將達到 190 萬，相當於每天約有 1,670 人死亡。慢性病盛行率的上升推動了自動注射器市場的成長，因為這些設備為需要定期服藥的患者提供了方便有效的解決方案。

預計不斷成長的醫療支出將推動自動注射器市場的發展。醫療支出是指特定醫療體系或經濟體在特定期間內用於醫療服務、商品和活動的總支出。醫療支出的成長促進了自動注射器的研發、價格承受能力和病患可近性。此外，對自動注射器日益成長的需求也推動了自動注射器開發領域的技術創新。例如，根據英國國家統計局2023年5月發布的報告，2020年至2021年，英國醫療保健支出名義成長9.4%，實際成長9.7%。 2021年，英國醫療保健總支出預計將達到3,672.5億美元（2,807億英鎊），其中藥品支出為518.4億美元（396億英鎊），預防保健支出為459.3億美元（351億英鎊），是2020年的兩倍多。因此，不斷增加的醫療保健支出在推動自動注射器市場方面發揮著重要作用。

技術進步正在顯著影響自動注射器市場。自動注射器領域的主要參與企業正致力於開發創新解決方案，以滿足黏性生技藥品傳輸機制的需求。例如，2023年5月，德國製藥公司勃林格殷格翰宣布，其用於Siltezo（Adalimumab-adbm）的自動注射器Siltezo Pen已獲得美國食品藥物管理局（FDA）的核准。 Siltezo已核准用於治療各種慢性發炎性疾病。 40毫克/0.8毫升預填充Siltezo Pen有兩支裝、四支裝和六支裝可供選擇。

為了滿足對永續藥物輸送設備日益成長的需求，自動注射器市場的主要企業正專注於開發創新產品，並為自我給藥輸送提供更具成本效益的解決方案。 Qfinity 自動注射器平台就是這樣一款創新產品，其設計既永續又價格實惠。該平台採用耐用材料，可承受 100 次以上的注射，並預填充盒式系統，可最大限度地減少廢棄物。例如，2022 年 5 月，美國醫療保健製造商 Jabil Inc. 推出了 Qfinity 自動注射器平台。該平台為自我給藥皮下 (SC) 藥物（包括大容量、高黏度藥物）提供了一種簡單、可重複使用的模組化解決方案。它提供永續性、經濟高效、多功能、易於使用、準確、安全、便攜和耐用的自我給藥輸送。

2022年4月，美國生技公司Halozyme Therapeutics, Inc.以9.6億美元收購了Antares Pharma。此次策略性收購旨在擴大Halozyme Therapeutics Inc.的藥物傳輸技術組合，並獲得Antares的商業基礎設施。此次收購將使該公司成為藥物傳輸領域的主要企業。 Antares是一家總部位於美國的藥物研發公司，專注於自動注射器的開發。此次收購將使該公司能夠向更廣泛的市場提供包括自動注射器在內的創新藥物輸送解決方案。

自動注射器市場的主要企業包括 AbbVie Inc.、Mylan NV、Eli Lilly and Company、Amgen Inc.、Becton、Dickinson and Company、Johnson & Johnson、Teva Pharmaceutical Industries Ltd.、Merck & Co. Inc.Inc.、PfizerInc.、BayerAG、Biogen Inc.、Merck & Co. Inc.Inc.、PfizerInc.、BayerAG、Biogen Inc.、Astraself. Morris International Inc.、Oval Medical Technologies Ltd.、Solteam Incorporation Co. Ltd.、Elcam Medical Group (E3D) Ltd.、Jabil Inc.、Catalent Inc.、SHL Medical AG、West Pharmaceutical Services Inc.、Nemera Development SA、Bespak Europe Ltd.、AptarGrolc* Corporation、OssDsign AB、Xenco Medical LLC 和 Renishaw plc。

2024年，自動注射器市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。自動注射器市場報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

自動注射器市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

自動注射器市場涵蓋一次性和可重複使用自動注射器的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售的商品價值，無論商品是銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）還是直接銷售給最終客戶。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球汽車注射器：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球自動注射器市場：成長率分析
• 全球自動注射器市場表現：規模與成長，2019-2024
• 全球自動注射器市場預測：規模與成長，2024-2029 年，2034 年
• 全球自動注射器：總目標市場（TAM）

第6章 市場細分

• 全球自動注射器市場類型、效能及預測（2019-2024、2024-2029、2034）
• 一次性自動注射器
• 可重複使用的自動注射器
• 全球自動注射器市場（按療法、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 類風濕性關節炎
• 多發性硬化症
• 糖尿病
• 過敏反應
• 其他
• 全球自動注射器市場（依給藥途徑）：2019-2024 年、2024-2029 年、2034 年績效及預測
• 皮下
• 肌肉注射
• 全球自動注射器市場（依通路）：2019-2024 年、2024-2029 年、2034 年業績及預測
• 線上零售商
• 藥局
• 全球自動注射器市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
• 居家照護
• 醫院和診所
• 其他
• 全球自動注射器市場：一次性自動注射器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 一次性自動注射器
• 預填充一次性自動注射器
• 全球自動注射器市場：可重複使用自動注射器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• 多功能可重複使用自動注射器
• 充電可重複使用自動注射器

第7章 區域和國家分析

• 全球自動注射器市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球自動注射器市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 自動注射器市場：競爭格局
• 自動注射器市場：公司簡介
  • AbbVie Inc.
  • Mylan NV
  • Eli Lilly and Company
  • Amgen Inc.
  • Becton, Dickinson and Company

第31章：其他領先和創新企業

• Johnson & Johnson
• Teva Pharmaceutical Industries Ltd.
• Merck & Co. Inc.
• Pfizer Inc.
• Bayer AG
• Biogen Inc.
• AstraZeneca PLC
• Haselmeier GmbH
• Owen Mumford Ltd.
• Gerresheimer AG
• Philip Morris International Inc.
• Oval Medical Technologies Ltd.
• Solteam Incorporation Co. Ltd.
• Elcam Medical Group（E3D）Ltd.
• Jabil Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

• 2029 年自動注射器市場：提供新機會的國家
• 2029 年自動注射器市場：細分市場帶來新機會
• 2029 年自動注射器市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

An autoinjector is a device designed for self-administering a single, predetermined dose of medication into the body. Typically, it features a spring-loaded syringe that is activated upon firm pressure against the body.

The primary types of autoinjectors are disposable autoinjectors and reusable autoinjectors. The market for disposable autoinjectors involves the sales of devices designed to replace traditional pre-filled syringes, aiming to eliminate psychological barriers by concealing the needle from the patient's view. These autoinjectors integrate a spring-powered mechanism with a shielded needle for subcutaneous or intramuscular administration of the required drug solution. They find application in various therapies such as rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and others, administered through routes like subcutaneous and intramuscular. Distribution channels include online retailers and pharmacies, and they are utilized in diverse settings, including home care, hospitals, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The autoinjectors market research report is one of a series of new reports from The Business Research Company that provides autoinjectors market statistics, including autoinjectors industry global market size, regional shares, competitors with an market share, detailed autoinjectors market segments, market trends and opportunities, and any further data you may need to thrive in the autoinjectors industry. This autoinjectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autoinjectors market size has grown exponentially in recent years. It will grow from $3.7 billion in 2024 to $4.51 billion in 2025 at a compound annual growth rate (CAGR) of 22.0%. The growth in the historic period can be attributed to increased prevalence of chronic diseases, growth in aging population, rise in biotechnology and pharmaceutical sector, rise in patient preference for self-administration, regulatory support.

The autoinjectors market size is expected to see exponential growth in the next few years. It will grow to $9.93 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to expansion of Therapeutic applications, rising healthcare costs, increased focus on patient-centered care, telemedicine and remote patient monitoring, emerging markets. Major trends in the forecast period include personalized drug delivery, connected and smart autoinjectors, needle-free autoinjectors, biologic drug delivery, safety and security features.

The forecast of 21.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through delays in acquiring German precision springs and Japanese needle safety mechanisms, potentially disrupting treatment for chronic conditions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to drive growth in the autoinjectors market in the upcoming years. Chronic diseases are defined as illnesses that last for a year or longer and require ongoing medical attention. Conditions such as heart disease, cancer, rheumatoid arthritis, and diabetes are among the leading causes of mortality and disability worldwide. Autoinjector devices are designed for multiple injections of biologics and hormones in patients who need regular doses for the long-term management of conditions like diabetes and rheumatoid arthritis. For example, in January 2022, research published by the American Cancer Society, a US-based health organization, projected that there would be 609,360 cancer deaths and 1.9 million new cancer cases in the US for that year, which translates to approximately 1,670 fatalities each day. This rising prevalence of chronic diseases is propelling the growth of the autoinjectors market, as these devices offer a convenient and effective solution for patients requiring regular medication.

Rising healthcare expenditure is anticipated to boost the autoinjectors market. Healthcare expenditure refers to the total amount of money spent on healthcare services, goods, and activities within a specific healthcare system or economy over a defined period. Increased healthcare expenditure supports the development, affordability, and accessibility of autoinjectors for patients. Moreover, greater demand for autoinjectors can drive innovation in the field of autoinjector development. As an illustration, according to a report published by the UK's Office for National Statistics in May 2023, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021. In 2021, total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion), with pharmaceutical expenditure at $51.84 billion (£39.6 billion), and spending on preventive care more than doubling from 2020, totaling $45.93 billion (£35.1 billion). Thus, rising healthcare expenditures are playing a significant role in propelling the autoinjectors market.

The rise of technological advancements is significantly influencing the autoinjectors market. Key players in the autoinjectors sector are concentrating on developing innovative solutions to fulfill the demand for a delivery mechanism for viscous biologics. For example, in May 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, announced that its Cyltezo Pen, an autoinjector option for Cyltezo (adalimumab-adbm), received approval from the U.S. Food and Drug Administration (FDA). Cyltezo is authorized for the treatment of various chronic inflammatory diseases. The 40 mg/0.8 mL pre-filled Cyltezo Pen will be available in packs of two, four, and six.

Major companies in the auto-injectors market are focused on developing innovative products to address the growing demand for sustainable drug delivery devices while offering more cost-effective solutions for self-administered drug delivery. One such innovative product is the Qfinity auto-injector platform, designed to be both sustainable and affordable. The platform incorporates durable materials capable of withstanding over 100 injections and features a pre-filled disposable cassette system that minimizes waste. For example, in May 2022, Jabil Inc., a US-based healthcare manufacturing company, introduced the Qfinity auto-injector platform. This platform is a straightforward, reusable, and modular solution for self-administering subcutaneous (SC) drugs, including larger-volume and higher-viscosity medicines. It offers sustainability, cost-effectiveness, versatility, ease of use, accuracy, safety, portability, and durability for self-administered drug delivery.

In April 2022, Halozyme Therapeutics Inc., a US-based biotechnology company, acquired Antares Pharma Inc. for $960 million. This strategic acquisition is aimed at expanding Halozyme Therapeutics Inc.'s portfolio of drug delivery technologies and gaining access to Antares' commercial infrastructure. The acquisition positions them to become a leading company in the field of drug delivery. Antares Pharma Inc. is a US-based pharmaceutical product development company specializing in the development of auto-injectors. This acquisition will likely enhance Halozyme's capabilities in delivering innovative drug delivery solutions, including auto-injectors, to a broader market.

Major companies operating in the autoinjectors market include AbbVie Inc., Mylan N.V., Eli Lilly and Company, Amgen Inc., Becton, Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Pfizer Inc., Bayer AG, Biogen Inc., AstraZeneca PLC, Haselmeier GmbH, Owen Mumford Ltd., Gerresheimer AG, Philip Morris International Inc., Oval Medical Technologies Ltd., Solteam Incorporation Co. Ltd., Elcam Medical Group (E3D) Ltd., Jabil Inc., Catalent Inc., SHL Medical AG, West Pharmaceutical Services Inc., Nemera Development S.A., Bespak Europe Ltd., AptarGroup Inc., Consort Medical plc, Terumo Corporation, Nipro Corporation, Medtronic plc, Integra LifeSciences Corporation, OssDsign AB, Xenco Medical LLC, Renishaw plc

North America was the largest region in the autoinjectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autoinjectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the autoinjectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The autoinjectors market consists of sales of disposable and reusable autoinjectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autoinjectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autoinjectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autoinjectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autoinjectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Disposable Autoinjectors; Reusable Autoinjectors
• 2) By Therapy: Rheumatoid Arthritis; Multiple Sclerosis; Diabetes; Anaphylaxis; Other Therapies
• 3) By Route Of Administration: Subcutaneous; Intramuscular
• 4) By Distribution Channel: Online Retailer; Pharmacy
• 5) By End User: Home Care Settings; Hospitals And Clinics; Other End-Users
• Subsegments:
• 1) By Disposable Autoinjectors: Single-Use Disposable Autoinjectors; Pre-filled Disposable Autoinjectors
• 2) By Reusable Autoinjectors: Multi-Use Reusable Autoinjectors; Rechargeable Reusable Autoinjectors
• Companies Mentioned: AbbVie Inc.; Mylan N.V.; Eli Lilly and Company; Amgen Inc.; Becton, Dickinson and Company; Johnson & Johnson; Teva Pharmaceutical Industries Ltd.; Merck & Co. Inc.; Pfizer Inc.; Bayer AG; Biogen Inc.; AstraZeneca PLC; Haselmeier GmbH; Owen Mumford Ltd.; Gerresheimer AG; Philip Morris International Inc.; Oval Medical Technologies Ltd.; Solteam Incorporation Co. Ltd.; Elcam Medical Group (E3D) Ltd.; Jabil Inc.; Catalent Inc.; SHL Medical AG; West Pharmaceutical Services Inc.; Nemera Development S.A.; Bespak Europe Ltd.; AptarGroup Inc.; Consort Medical plc; Terumo Corporation; Nipro Corporation; Medtronic plc; Integra LifeSciences Corporation; OssDsign AB; Xenco Medical LLC; Renishaw plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autoinjectors Market Characteristics

3. Autoinjectors Market Trends And Strategies

4. Autoinjectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Autoinjectors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Autoinjectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Autoinjectors Market Growth Rate Analysis
• 5.4. Global Autoinjectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Autoinjectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Autoinjectors Total Addressable Market (TAM)

6. Autoinjectors Market Segmentation

• 6.1. Global Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Autoinjectors
• Reusable Autoinjectors
• 6.2. Global Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Anaphylaxis
• Other Therapies
• 6.3. Global Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous
• Intramuscular
• 6.4. Global Autoinjectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Retailer
• Pharmacy
• 6.5. Global Autoinjectors Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Care Settings
• Hospitals And Clinics
• Other End-Users
• 6.6. Global Autoinjectors Market, Sub-Segmentation Of Disposable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Disposable Autoinjectors
• Pre-filled Disposable Autoinjectors
• 6.7. Global Autoinjectors Market, Sub-Segmentation Of Reusable Autoinjectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Use Reusable Autoinjectors
• Rechargeable Reusable Autoinjectors

7. Autoinjectors Market Regional And Country Analysis

• 7.1. Global Autoinjectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Autoinjectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autoinjectors Market

• 8.1. Asia-Pacific Autoinjectors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autoinjectors Market

• 9.1. China Autoinjectors Market Overview
• 9.2. China Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autoinjectors Market

• 10.1. India Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autoinjectors Market

• 11.1. Japan Autoinjectors Market Overview
• 11.2. Japan Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autoinjectors Market

• 12.1. Australia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autoinjectors Market

• 13.1. Indonesia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autoinjectors Market

• 14.1. South Korea Autoinjectors Market Overview
• 14.2. South Korea Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autoinjectors Market

• 15.1. Western Europe Autoinjectors Market Overview
• 15.2. Western Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autoinjectors Market

• 16.1. UK Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autoinjectors Market

• 17.1. Germany Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autoinjectors Market

• 18.1. France Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autoinjectors Market

• 19.1. Italy Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autoinjectors Market

• 20.1. Spain Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autoinjectors Market

• 21.1. Eastern Europe Autoinjectors Market Overview
• 21.2. Eastern Europe Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autoinjectors Market

• 22.1. Russia Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autoinjectors Market

• 23.1. North America Autoinjectors Market Overview
• 23.2. North America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autoinjectors Market

• 24.1. USA Autoinjectors Market Overview
• 24.2. USA Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autoinjectors Market

• 25.1. Canada Autoinjectors Market Overview
• 25.2. Canada Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autoinjectors Market

• 26.1. South America Autoinjectors Market Overview
• 26.2. South America Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autoinjectors Market

• 27.1. Brazil Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autoinjectors Market

• 28.1. Middle East Autoinjectors Market Overview
• 28.2. Middle East Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autoinjectors Market

• 29.1. Africa Autoinjectors Market Overview
• 29.2. Africa Autoinjectors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Autoinjectors Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Autoinjectors Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autoinjectors Market Competitive Landscape And Company Profiles

• 30.1. Autoinjectors Market Competitive Landscape
• 30.2. Autoinjectors Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Autoinjectors Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Merck & Co. Inc.
• 31.4. Pfizer Inc.
• 31.5. Bayer AG
• 31.6. Biogen Inc.
• 31.7. AstraZeneca PLC
• 31.8. Haselmeier GmbH
• 31.9. Owen Mumford Ltd.
• 31.10. Gerresheimer AG
• 31.11. Philip Morris International Inc.
• 31.12. Oval Medical Technologies Ltd.
• 31.13. Solteam Incorporation Co. Ltd.
• 31.14. Elcam Medical Group (E3D) Ltd.
• 31.15. Jabil Inc.

32. Global Autoinjectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autoinjectors Market

34. Recent Developments In The Autoinjectors Market

35. Autoinjectors Market High Potential Countries, Segments and Strategies

• 35.1 Autoinjectors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Autoinjectors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Autoinjectors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer